Alnylam Pharmaceuticals
ALNY
#622
Rank
HK$245.97 B
Marketcap
HK$1,907
Share price
2.75%
Change (1 day)
34.81%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company